Overview

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Status:
Recruiting
Trial end date:
2023-03-14
Target enrollment:
Participant gender:
Summary
First-in-human, Phase I/II, Multicenter, Open-Label Study of EMB-01 in Patients with Advanced/Metastatic Solid Tumors
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai EpimAb Biotherapeutics Co., Ltd.
Collaborator:
Covance